Multiple sclerosis: it epidemiological, genetic, and health care impact.
作者信息
Williams R, Rigby A S, Airey M, Robinson M, Ford H
机构信息
Division of Public Health, Nuffield Institute of Health, Leeds.
出版信息
J Epidemiol Community Health. 1995 Dec;49(6):563-9. doi: 10.1136/jech.49.6.563.
Abstract
摘要
相似文献
1
Multiple sclerosis: it epidemiological, genetic, and health care impact.
J Epidemiol Community Health. 1995 Dec;49(6):563-9. doi: 10.1136/jech.49.6.563.
2
Genetic epidemiology of multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):553-61. doi: 10.1136/jnnp.62.6.553.
3
Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies.
J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):906-11. doi: 10.1136/jnnp.53.10.906.
4
The epidemiology of multiple sclerosis.
Mayo Clin Proc. 1997 Sep;72(9):871-8. doi: 10.4065/72.9.871.
5
Multiple sclerosis in Malta in 1999.
J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):239-40. doi: 10.1136/jnnp.73.3.239-a.
6
Consanguinity and multiple sclerosis in Orkney.
Genet Epidemiol. 1991;8(3):147-51. doi: 10.1002/gepi.1370080302.
7
The role of the PTPRC (CD45) mutation in the development of multiple sclerosis in the North West region of the United Kingdom.
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):944-5. doi: 10.1136/jnnp.74.7.944.
8
[Genetic susceptibility to multiple sclerosis (MS). INSERM Network of Clinical Research on the Genetic Susceptibility to MS].
Rev Neurol (Paris). 1998 Sep;154(8-9):601-5.
9
The epidemiology of multiple sclerosis.
Acta Neurol Scand Suppl. 1997;169:3-7. doi: 10.1111/j.1600-0404.1997.tb08143.x.
10
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Brain. 2000 May;123 ( Pt 5):968-74. doi: 10.1093/brain/123.5.968.
引用本文的文献
1
Estimation the medical cost of multiple sclerosis in Iran; 2019-2020.
BMC Health Serv Res. 2022 Feb 2;22(1):137. doi: 10.1186/s12913-022-07551-z.
2
A quantitative systems pharmacology model of colonic motility with applications in drug development.
J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):485-498. doi: 10.1007/s10928-019-09651-6. Epub 2019 Aug 20.
3
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis.
Brain Behav. 2015 Sep;5(9):e00362. doi: 10.1002/brb3.362. Epub 2015 Aug 3.
4
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.
Biologics. 2013;7:247-58. doi: 10.2147/BTT.S53007. Epub 2013 Nov 27.
5
Economic evaluation of multiple sclerosis in the UK, Germany and France.
Pharmacoeconomics. 1998 May;13(5 Pt 2):607-22. doi: 10.2165/00019053-199813050-00013.
6
Quality of reviews in epidemiology.
Am J Public Health. 1998 Mar;88(3):475-7. doi: 10.2105/ajph.88.3.475.
本文引用的文献
1
New concept of critical steps in course of chronic debilitating neurologic disease in evaluation of therapeutic response; a longitudinal study of multiple sclerosis by quantitative evaluation of neurologic involvement and disability.
AMA Arch Neurol Psychiatry. 1951 Sep;66(3):253-71. doi: 10.1001/archneurpsyc.1951.02320090002001.
2
Tetraethylammonium chloride in the treatment of multiple sclerosis.
AMA Arch Neurol Psychiatry. 1950 Oct;64(4):536-45. doi: 10.1001/archneurpsyc.1950.02310280048005.
3
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THE COUNTIES OF NORTHUMBERLAND AND DURHAM.
J Neurol Neurosurg Psychiatry. 1963 Aug;26(4):368-76. doi: 10.1136/jnnp.26.4.368.
4
The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease.
Brain. 1961 Jun;84:186-203. doi: 10.1093/brain/84.2.186.
5
Patients with multiple sclerosis enter lottery.
BMJ. 1993 Oct 16;307(6910):958.
6
A population-based study of multiple sclerosis in twins: update.
Ann Neurol. 1993 Mar;33(3):281-5. doi: 10.1002/ana.410330309.
7
[Intermittent self-catheterization in multiple sclerosis].
Sairaanhoitaja (1991). 1993(1):17-20.
8
Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group.
Arch Phys Med Rehabil. 1993 Jan;74(1):26-31.
9
Ascertainment corrected rates: applications of capture-recapture methods.
Int J Epidemiol. 1993 Jun;22(3):559-65. doi: 10.1093/ije/22.3.559.
10
Self-care and multiple sclerosis: a view from two cultures.
Soc Sci Med. 1993 Aug;37(3):315-29. doi: 10.1016/0277-9536(93)90263-4.
Zotero 插件